Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]

Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]

Bibliographic Details
Main Authors: Pradip De, Yuling Sun, Jennifer H. Carlson, Lori S. Friedman, Brian R. Leyland-Jones, Nandini Dey
Format: Article
Language:English
Published: Elsevier 2014-04-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558614000311
id doaj-58c678585f3a4804baf55a9aee07b1bb
record_format Article
spelling doaj-58c678585f3a4804baf55a9aee07b1bb2020-11-24T21:20:52ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022014-04-0116437510.1016/j.neo.2014.03.012Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]Pradip DeYuling SunJennifer H. CarlsonLori S. FriedmanBrian R. Leyland-JonesNandini Deyhttp://www.sciencedirect.com/science/article/pii/S1476558614000311
collection DOAJ
language English
format Article
sources DOAJ
author Pradip De
Yuling Sun
Jennifer H. Carlson
Lori S. Friedman
Brian R. Leyland-Jones
Nandini Dey
spellingShingle Pradip De
Yuling Sun
Jennifer H. Carlson
Lori S. Friedman
Brian R. Leyland-Jones
Nandini Dey
Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
Neoplasia: An International Journal for Oncology Research
author_facet Pradip De
Yuling Sun
Jennifer H. Carlson
Lori S. Friedman
Brian R. Leyland-Jones
Nandini Dey
author_sort Pradip De
title Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_short Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_full Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_fullStr Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_full_unstemmed Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
title_sort erratum to “doubling down on the pi3k-aktmtor pathway enhances the antitumor efficacy of parp inhibitor in triple negative breast cancer model beyond brca-ness” [neoplasia 16 (2014) 43–72]
publisher Elsevier
series Neoplasia: An International Journal for Oncology Research
issn 1476-5586
1522-8002
publishDate 2014-04-01
url http://www.sciencedirect.com/science/article/pii/S1476558614000311
work_keys_str_mv AT pradipde erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT yulingsun erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT jenniferhcarlson erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT lorisfriedman erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT brianrleylandjones erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
AT nandinidey erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372
_version_ 1726002477357072384

Similar Items